Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Farah Wise

Optometrist, Corneal and Contact Management Beaufort, SC Doctor of Optometry

NPI 1851350201 CMS profile 700936

1270 Ribaut Rd, Beaufort, SC 29902

Open in the dashboard

General payments

$1,269

16 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Farah Wise of Beaufort, SC is reported in the CMS Open Payments database as having received $1,269 across 16 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Optometrist, Corneal and Contact Management profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,016 3
2024 General $36 2
2023 General $16 1
2022 General $13 1
2021 General $175 8
2019 General $13 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Farah Wise
  • Optometrist, Corneal and Contact Management median
  • Middle half of Optometrist, Corneal and Contact Management
  • National median

In program year 2025, general payments to Farah Wise were reported at $1,016. Among 618 Optometrist, Corneal and Contact Management profiles paid that year, the median was $227 and the middle half received between $95 and $604.

Show as a table
Year Farah Wise Optometrist, Corneal and Contact Management median Middle half National median
2019 $13 $203 $84–$530 $163
2020 $0 $88 $35–$234 $114
2021 $175 $143 $54–$353 $132
2022 $13 $167 $65–$422 $149
2023 $16 $195 $76–$549 $160
2024 $36 $202 $85–$523 $164
2025 $1,016 $227 $95–$604 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lumenis BE inc $974 1 payment
  2. Alcon Vision LLC $204 10 payments
  3. Johnson & Johnson Vision Care, Inc. $57 3 payments
  4. AbbVie, Inc. $22 1 payment
  5. CooperVision Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,269 16 payments
Products named General payments · program years 2019–2025
  1. optilight $974 1 payment
  2. DAILIES $98 5 payments
  3. Precision 1 $72 3 payments
  4. LUMIGAN $22 1 payment
  5. ILUX $18 1 payment
  6. TOTAL30 $16 1 payment
  7. Clariti Contact Lens $14 1 payment
  8. Acuvue $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

190

Median for Optometry: 120

Drug cost

$34,201

Median for Optometry: $8,864

Branded share of claims

28.9%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Restasis Cyclosporine Brand 24 $17,719
Lumigan Bimatoprost Brand 20 $14,466
Latanoprost Generic 120 $1,330
Tobramycin-Dexamethasone Tobramycin/Dexamethasone Brand 11 $633
Timolol Maleate Generic 15 $53

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$37,849

Medicare's payments for the services billed

Medicare patients

368

Average age 72

Services billed

736

221 women, 147 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 39%
Diabetes 23%
Ischemic heart disease 17%
Chronic kidney disease 16%
Cancer 14%
Atrial fibrillation 11%
Depression 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

16 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist, Corneal and Contact Management in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record